Process Validation Software Designed for the Life Sciences
Eliminate data integrity issues. Ensure consistent product quality.
Complete, compliant system: ValGenesis offers users a lifecycle approach to process validation in compliance with 21 CFR Part 11, Annex 11 and ALCOA data integrity principles. The solution also complies with the FDA Guidance for Industry: Process Validation: General Principles and Practices (2011) and enables cGMP regulations for validating pharmaceutical (drug) manufacturing processes to meet all the attributes they are intended to possess: 21 CFR 211.100(a) and 211.110(a).
Holistic validation management: The solution is tightly coupled with other ValGenesis solutions, including analytical method validation, cleaning validation, and equipment and instrument validation, for a holistic approach to validation management.
Risk-based approach: Using risk assessment models, our VLMS helps you conduct a risk assessment and mitigation plan for process design, parameters and attributes (e.g., CMA, CPP and CQA). The risk assessment approach is also used to identify the number of batches to be taken as part of process performance qualification (PPQ) with required justification and approvals.
Increased data integrity: Our VLMS dynamically collects the critical control points (CCPs), as per the predefined schedules, and updates batch records to eliminate human error and provide a higher degree of data integrity.
100% paperless: With ValGenesis, all validation deliverables are created, reviewed and approved electronically, entirely eliminating paper from the validation process.
Process validation master plan: Our process validation master plan drives all stages of process validation and enforces the required studies and deliverables at every stage with required dependencies between studies and deliverables.